Literature DB >> 18280875

Medically indicated preterm birth: recognizing the importance of the problem.

Cande V Ananth1, Anthony M Vintzileos.   

Abstract

Preterm birth complicates over 500,000 births annually, affecting 12.5% of pregnancies in the United States. Much of the temporal increase in preterm birth (<37 weeks) over the past decade is largely driven by a concurrent temporal increase in medically indicated preterm birth. Maternal and fetal indications that prompt an intervention at preterm gestational ages include preeclampsia, intrauterine growth restriction, and placental abruption-conditions that constitute "ischemic placental disease." Ischemic placental disease is implicated in over one of every two indicated preterm births compared with less than one in five births at term. Comprehensive evaluation of risk factors, with careful consideration of heterogeneity in the syndrome of medically indicated preterm birth and ischemic placental disease may provide important clues to predict and consequently prevent preterm birth.

Entities:  

Mesh:

Year:  2008        PMID: 18280875     DOI: 10.1016/j.clp.2007.11.001

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  37 in total

1.  Disturbed sleep, a novel risk factor for preterm birth?

Authors:  Michele L Okun; James F Luther; Stephen R Wisniewski; Dorothy Sit; Beth A Prairie; Katherine L Wisner
Journal:  J Womens Health (Larchmt)       Date:  2011-10-03       Impact factor: 2.681

2.  Associations of LINE-1 DNA Methylation with Preterm Birth in a Prospective Cohort Study.

Authors:  Heather H Burris; Sheryl L Rifas-Shiman; Andrea Baccarelli; Letizia Tarantini; Caroline E Boeke; Ken Kleinman; Augusto A Litonjua; Janet W Rich-Edwards; Matthew W Gillman
Journal:  J Dev Orig Health Dis       Date:  2012-06       Impact factor: 2.401

Review 3.  Maternal, Labor, Delivery, and Perinatal Outcomes Associated with Placental Abruption: A Systematic Review.

Authors:  Katheryne L Downes; Katherine L Grantz; Edmond D Shenassa
Journal:  Am J Perinatol       Date:  2017-03-22       Impact factor: 1.862

4.  Exposures to Air Pollution and Risk of Acute-onset Placental Abruption: A Case-crossover Study.

Authors:  Cande V Ananth; Marianthi-Anna Kioumourtzoglou; Yongmei Huang; Zev Ross; Alexander M Friedman; Michelle A Williams; Shuang Wang; Murray A Mittleman; Joel Schwartz
Journal:  Epidemiology       Date:  2018-09       Impact factor: 4.822

5.  Association Between Temporal Changes in Neonatal Mortality and Spontaneous and Clinician-Initiated Deliveries in the United States, 2006-2013.

Authors:  Cande V Ananth; Alexander M Friedman; Robert L Goldenberg; Jason D Wright; Anthony M Vintzileos
Journal:  JAMA Pediatr       Date:  2018-10-01       Impact factor: 16.193

6.  Circadian clock-related genetic risk scores and risk of placental abruption.

Authors:  Chunfang Qiu; Bizu Gelaye; Marie Denis; Mahlet G Tadesse; Miguel Angel Luque Fernandez; Daniel A Enquobahrie; Cande V Ananth; Sixto E Sanchez; Michelle A Williams
Journal:  Placenta       Date:  2015-10-23       Impact factor: 3.481

7.  Characteristics of childbearing women, obstetrical interventions and preterm delivery: a comparison of the US and France.

Authors:  Jennifer Zeitlin; Béatrice Blondel; Cande V Ananth
Journal:  Matern Child Health J       Date:  2015-05

8.  Primary and Repeat Cesarean Deliveries: A Population-based Study in the United States, 1979-2010.

Authors:  Cande V Ananth; Alexander M Friedman; Katherine M Keyes; Jessica A Lavery; Ava Hamilton; Jason D Wright
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

9.  Antidepressant use and risk for preeclampsia.

Authors:  Kristin Palmsten; Krista F Huybrechts; Karin B Michels; Paige L Williams; Helen Mogun; Soko Setoguchi; Sonia Hernández-Díaz
Journal:  Epidemiology       Date:  2013-09       Impact factor: 4.822

10.  The challenge of infant mortality: have we reached a plateau?

Authors:  Marian F MacDorman; T J Mathews
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.